Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-Acting β-Agonist PF-00610355.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 6, p. 443, doi. 10.1007/s40262-013-0048-7
- By:
- Publication type:
- Article
Works matching IS 03125963 AND DT 2013 AND VI 52 AND IP 6
Results: 9
1
2
Characterizing systemic exposure of inhaled drugs: application to the long-acting β2-agonist PF-00610355.
- Published in:
- 2013
- By:
- Publication type:
- journal article
3
A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
- Published in:
- 2013
- By:
- Publication type:
- journal article
4
A Population Pharmacokinetic Model for Low-Dose Methotrexate and its Polyglutamated Metabolites in Red Blood Cells.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 6, p. 475, doi. 10.1007/s40262-013-0052-y
- By:
- Publication type:
- Article
5
Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 6, p. 399, doi. 10.1007/s40262-013-0040-2
- By:
- Publication type:
- Article
6
Pharmacometric Characterization of Dabigatran Hemodialysis.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 6, p. 453, doi. 10.1007/s40262-013-0049-6
- By:
- Publication type:
- Article
7
Prediction of Drug Disposition on the Basis of its Chemical Structure.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 6, p. 415, doi. 10.1007/s40262-013-0042-0
- By:
- Publication type:
- Article
8
Disposition Pathway-Dependent Approach for Predicting Organic Anion-Transporting Polypeptide-Mediated Drug-Drug Interactions.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 6, p. 433, doi. 10.1007/s40262-013-0045-x
- By:
- Publication type:
- Article
9
A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [C]Tofogliflozin in Humans.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 6, p. 463, doi. 10.1007/s40262-013-0051-z
- By:
- Publication type:
- Article